Z-1571-2016 Class II Terminated

Recalled by Hardy Diagnostics — Santa Maria, CA

FDA device recall Z-1571-2016 was initiated by Hardy Diagnostics on Mar 21, 2016 and is designated Class II. Reason for recall: Performance failure; poor hemolytic reaction of non or weakly hemolytic group B streptococcus (GBS) with the target QC organism, Streptococcus agalactiae (ATCC 13813) due to product deterioration. The recall status is terminated (terminated Oct 25, 2016). Affected quantity: 3,530 (353 pk/10).

Recall details

Product Type
Devices
Report Date
May 4, 2016
Initiation Date
Mar 21, 2016
Termination Date
Oct 25, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,530 (353 pk/10)

Product description

Hardy Diagnostics GBS Detect Cat no. A300. Used for the isolation and detection by enhanced hemolysis of gamma-hemolytic (non-hemolytic) Group B Streptococcus.

Reason for recall

Performance failure; poor hemolytic reaction of non or weakly hemolytic group B streptococcus (GBS) with the target QC organism, Streptococcus agalactiae (ATCC 13813) due to product deterioration.

Distribution pattern

U.S. Distribution to the following states: AL, SC, FL, CT, VA, WI, MA, MI, WV, OH, IN, IL, NC, and TX.

Code information

Lot H16054 and H15056.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1571-2016
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Hardy Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-1571-2016. Report a data issue: hello@regdatalab.com.